Simplifying Global Compliance
HPV Tests Should Include Non-Vaccine Genotypes, U.S. Guidance Says
International Medical Device Regulatory Monitor
Companies developing diagnostics for human papillomavirus (HPV) should be alert for the impact of HPV vaccines on the potential test subject population, the U.S. Food and Drug Administration (FDA) says.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing